Reni Benjamin
Stock Analyst at Citizens JMP
(0.05)
# 4,536
Out of 4,564 analysts
814
Total ratings
33.8%
Success rate
-9.7%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintained: Buy | $35 → $41 | $23.60 | +73.73% | 47 | Apr 23, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $8 | $3.83 | +108.88% | 1 | Apr 16, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $5 → $8 | $1.82 | +339.56% | 36 | Apr 14, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 → $8 | $4.16 | +92.31% | 37 | Mar 18, 2026 | |
| IMMP Immutep | Downgraded: Hold | n/a | $0.3924 | - | 2 | Mar 13, 2026 | |
| PRLD Prelude Therapeutics | Maintained: Buy | $3 → $6 | $3.93 | +52.67% | 15 | Mar 11, 2026 | |
| LYEL Lyell Immunopharma | Initiated Coverage: Buy | $34 | $12.78 | +166.04% | 1 | Mar 9, 2026 | |
| IMMX Immix Biopharma | Initiated Coverage: Buy | $23 | $8.80 | +161.36% | 1 | Mar 9, 2026 | |
| IOVA Iovance Biotherapeutics | Upgraded: Buy | $5 | $5.13 | -2.53% | 49 | Feb 25, 2026 | |
| BCAX Bicara Therapeutics | Initiated Coverage: Buy | $31 | $27.73 | +11.79% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.3602 | - | 12 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $23.12 | +38.41% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.12 | +371.70% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $348 → $396 | $326.77 | +21.19% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $8 | $3.21 | +149.22% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.42 | - | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $10.45 | +129.67% | 41 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $116.69 | - | 105 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.46 | - | 23 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $14.98 | +167.02% | 8 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.20 | - | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $85.00 | n/a | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $33.09 | n/a | 27 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.34 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.18 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.18 | n/a | 20 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $0.0286 | n/a | 19 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.01 | n/a | 24 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $58.87 | n/a | 1 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $5 | $1.07 | n/a | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $57 | $42.50 | n/a | 14 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 → $94 | $10.25 | n/a | 12 | Feb 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $1.22 | n/a | 4 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 | $1.92 | n/a | 25 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $3.09 | n/a | 9 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $8.37 | n/a | 17 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $13 | $0.661 | n/a | 16 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $55.50 | n/a | 25 | Aug 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.45 | n/a | 8 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.52 | n/a | 21 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.40 | n/a | 14 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.34 | n/a | 10 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.03432 | n/a | 7 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0004 | n/a | 1 | May 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.66 | n/a | 7 | May 21, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | May 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $3.23 | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $1.07 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $19.83 | n/a | 7 | Mar 19, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.80 | n/a | 4 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.19 | n/a | 6 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.0001 | n/a | 6 | Dec 11, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.02 | n/a | 3 | Oct 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $36.35 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 | $15.88 | n/a | 1 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.45 | n/a | 2 | Oct 12, 2010 |
Sutro Biopharma
Apr 23, 2026
Maintained: Buy
Price Target: $35 → $41
Current: $23.60
Upside: +73.73%
Whitehawk Therapeutics
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $3.83
Upside: +108.88%
Allogene Therapeutics
Apr 14, 2026
Maintained: Buy
Price Target: $5 → $8
Current: $1.82
Upside: +339.56%
Bicycle Therapeutics
Mar 18, 2026
Maintained: Buy
Price Target: $12 → $8
Current: $4.16
Upside: +92.31%
Immutep
Mar 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3924
Upside: -
Prelude Therapeutics
Mar 11, 2026
Maintained: Buy
Price Target: $3 → $6
Current: $3.93
Upside: +52.67%
Lyell Immunopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $12.78
Upside: +166.04%
Immix Biopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $8.80
Upside: +161.36%
Iovance Biotherapeutics
Feb 25, 2026
Upgraded: Buy
Price Target: $5
Current: $5.13
Upside: -2.53%
Bicara Therapeutics
Jan 29, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $27.73
Upside: +11.79%
Dec 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.3602
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $23.12
Upside: +38.41%
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.12
Upside: +371.70%
Nov 7, 2025
Maintained: Buy
Price Target: $348 → $396
Current: $326.77
Upside: +21.19%
Oct 30, 2025
Maintained: Buy
Price Target: $5 → $8
Current: $3.21
Upside: +149.22%
Oct 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.42
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: $24
Current: $10.45
Upside: +129.67%
Sep 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $116.69
Upside: -
Sep 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.46
Upside: -
Sep 8, 2025
Reiterated: Buy
Price Target: $40
Current: $14.98
Upside: +167.02%
Aug 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.20
Upside: -
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $85.00
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: $2
Current: $33.09
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.34
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $4.18
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 10, 2019
Downgraded: Hold
Price Target: n/a
Current: $6.18
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $16 → $6
Current: $0.0286
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: n/a
Current: $4.01
Upside: n/a
Apr 9, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $58.87
Upside: n/a
Mar 18, 2019
Maintained: Buy
Price Target: $6 → $5
Current: $1.07
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $73 → $57
Current: $42.50
Upside: n/a
Feb 5, 2019
Upgraded: Buy
Price Target: $96 → $94
Current: $10.25
Upside: n/a
Dec 13, 2018
Maintained: Buy
Price Target: $21
Current: $1.22
Upside: n/a
Nov 15, 2018
Upgraded: Buy
Price Target: $5
Current: $1.92
Upside: n/a
Nov 14, 2018
Upgraded: Buy
Price Target: n/a
Current: $3.09
Upside: n/a
Oct 12, 2018
Maintained: Buy
Price Target: $11 → $10
Current: $8.37
Upside: n/a
Aug 28, 2018
Maintained: Buy
Price Target: $13 → $13
Current: $0.661
Upside: n/a
Aug 14, 2018
Maintained: Buy
Price Target: $22
Current: $55.50
Upside: n/a
Aug 10, 2018
Maintained: Hold
Price Target: n/a
Current: $0.45
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $2.52
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $7.40
Upside: n/a
Dec 18, 2017
Rated: Hold
Price Target: n/a
Current: $12.34
Upside: n/a
Jun 4, 2015
Reiterated: Buy
Price Target: $6
Current: $0.03432
Upside: n/a
May 26, 2015
Initiated Coverage: Buy
Price Target: $13
Current: $0.0004
Upside: n/a
May 21, 2015
Maintained: Buy
Price Target: $8
Current: $1.66
Upside: n/a
May 15, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $7 → $3
Current: $3.23
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $9 → $5
Current: $1.07
Upside: n/a
Mar 19, 2015
Reiterated: Buy
Price Target: $8 → $12
Current: $19.83
Upside: n/a
Feb 18, 2015
Reiterated: Buy
Price Target: $4
Current: $1.80
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $6
Current: $6.19
Upside: n/a
Dec 11, 2014
Maintained: Buy
Price Target: $40
Current: $0.0001
Upside: n/a
Oct 13, 2014
Maintained: Hold
Price Target: n/a
Current: $2.02
Upside: n/a
May 5, 2014
Initiated Coverage: Buy
Price Target: $17
Current: $36.35
Upside: n/a
Jul 24, 2013
Downgraded: Hold
Price Target: $39
Current: $15.88
Upside: n/a
Oct 12, 2010
Reiterated: Buy
Price Target: $9
Current: $1.45
Upside: n/a